3010 301096 3 Jun 2024 | Other | ¥0.3 Per Share |
3010 301096 4 May 2023 | Other | ¥0.8 Per Share |
3010 301096 18 Apr 2022 | Other | ¥0.6 Per Share |
28 Oct 2024 Date | | - Cons. EPS | 0.07 EPS |
22 Apr 2024 Date | | - Cons. EPS | 0.46 EPS |
25 Oct 2023 Date | | - Cons. EPS | 0.76 EPS |
3010 301096 3 Jun 2024 | Other | ¥0.3 Per Share |
3010 301096 4 May 2023 | Other | ¥0.8 Per Share |
3010 301096 18 Apr 2022 | Other | ¥0.6 Per Share |
28 Oct 2024 Date | | - Cons. EPS | 0.07 EPS |
22 Apr 2024 Date | | - Cons. EPS | 0.46 EPS |
25 Oct 2023 Date | | - Cons. EPS | 0.76 EPS |
Drug Manufacturers - General Industry | Healthcare Sector | Ms. Jinfang Lou CEO | XSHE Exchange | CNE1000056N5 ISIN |
CN Country | 1,834 Employees | - Last Dividend | - Last Split | - IPO Date |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd., founded in 2011 and based in Hangzhou, China, is a pharmaceutical technology research, development, and services enterprise. The company plays a crucial role in the pharmaceutical industry by focusing on various phases of drug research and development. Its operations span across the essential processes of drug discovery, including pharmaceutical research, clinical trials, customized research and development and production, and the application for product registration. Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. is committed to transforming research and development technology results, catering to pharmaceutical and pharmaceutical research and development investment companies across China.
Offers comprehensive services in the initial stages of drug discovery, facilitating the development of pharmaceuticals through innovative research methodologies and cutting-edge technologies.
Specializes in transforming the outcomes of pharmaceutical research into tangible, market-ready products, ensuring that new discoveries are rapidly and efficiently brought to market.
Provides investment opportunities in the pharmaceutical research and development sector, supporting the advancement of new and existing pharmaceutical products.
Offers tailored research and development services that meet the specific needs of their clients, including customized production processes to ensure the highest quality of pharmaceutical products.
Assists in the preparation and submission of registration applications for new drugs, ensuring compliance with regulatory standards and facilitating the approval process.